Signaling events mediate many processes that act during embryogenesis to initiate the program of early development. Within the cell many of these changes are mediated through the activation or inactivation of kinases and phosphatases. Protein kinase C (PKC) is one kinase that has been shown to be involved in at least two developmental transitions during early development, fertilization and embryonic compaction. PKC is a family of kinases whose various isotypes have differing requirements for activation of the kinase that include the availability of calcium, diacylglycerol, and negatively charged phospholipids. The presence of more than one isotype in an egg or blastomere of the embryo would provide the possibility that different isotypes mediate distinct signaling pathways in the cells. To address this possibility the different isotypes of PKC were examined at the mRNA and protein levels during preimplantation development in the mouse. Our results demonstrate that seven isotypes of PKC are present during preimplantation development in mouse, some are of maternal origin and others appear after fertilization. Two isotypes have a stage-dependent nuclear localization. In addition, within each blastomere PKC isotypes occupy different subcellular locations in a stage-dependent fashion.
INTRODUCTION
Embryonic development requires that a wide variety of information be relayed via intracellular signaling pathways in blastomeres of the embryo. A number of these signals are transduced into a cell through cell surface receptors which, upon binding to their ligand, initiate one or more signal transduction cascades and alter the state of phosphorylation of various intracellular components through the action of both kinases and phosphatases. One of these signal transducers is protein kinase C (PKC), which functions during fertilization (Ducibella et al., 1993; Gallicano et al., 1993 Gallicano et al., , 1995 Gallicano et al., , 1997a Raz et al., 1998) and embryonic compaction (Winkel et al., 1990; Ohsugi et al., 1993a; Pauken and Capco, 1999a) . Since PKC is represented by a family of 11 different kinases, many with distinct activation requirements, PKCs could function to decode complex signals transduced into the cell by surface receptors (Hofmann, 1997; Toker, 1998) . The conventional PKC isotypes, ␣, ␤I, ␤II, and ␥, are activated by negatively charged phospholipids and diacylglycerol (DAG) in a calcium-dependent manner. The novel PKC isotypes ␦, ⑀, , , and require negatively charged phospholipids and DAG as cofactors, but do not have a requirement for calcium. PKC, also known as PKD, has a unique structure and some investigators regard this isotype as a different category of kinase (Johannes et al., 1994) . The atypical PKC isotypes and do not require calcium or DAG, but do require negatively charged phospholipids. Each cell can contain more than one isotype of PKC in distinct spatial patterns (Gallicano et al., 1997b; Oehrlein et al., 1998) . Thus, depending on the signaling cascades stimulated in the somatic cell, egg, or blastomeres of the embryo, different isotypes of the PKC family could become active. Recently, it has been suggested that some isotypes of PKC may also serve to decode calcium oscillations as well as DAG signals (Oancea and Meyer, 1998) and thus could serve to decode the calcium oscillations that result from fertilization of mammalian eggs.
Specific PKCs have been reported to have a role in the developmental fate specification of different tissues as well as the differentiation of several cell types. For example, the differentiation of the embryonal teratocarcinoma cell line, F9, is accompanied by increases in PKC␣ at both the mRNA and the protein levels, while there are decreases in the levels of mRNAs coding for PKC␤ and ␥ (Kindregan et al., 1994) . The epitheliomesenchymal transition which occurs in the neural epithelium can be induced in culture by treatment of explants with PKC inhibitors (Minichiello et al., 1999) . In addition, there also is a differential expression of PKC isotypes within neural tissue and somatic epithelium during development (Minichiello et al., 1999) . Primary cultures of hippocampal cells express the PKCs ␣, ␤I, ␥, , , and constitutively while PKCs ␤II, ␦, ⑀, and are upregulated upon the induction of differentiation with retinoic acid treatment (Oehrlein et al., 1998) . Moreover, these PKCs occupy different subcellular compartments within the cell, suggesting that they may function within specific regions of the cell (Oehrlein et al., 1998) .
A number of different PKC isotypes have been reported to exist in mammalian eggs and oocytes. Analysis of rat metaphase II eggs detected mRNA and protein for PKC␣, ␤, ␥, ␦, ⑀, , , and (Raz et al., 1998) . In this system, PKC␣, ␤, and ␥ translocated to the plasma membrane upon activation of the kinase (Raz et al., 1998) . This observation supports our earlier work using a PKC reporter dye that detects many PKC isotypes, which showed that PKC became active and translocated to the plasma membrane of mammalian eggs as a result of egg activation and fertilization (Gallicano et al., 1995 (Gallicano et al., , 1997a . Specific PKC isotypes also have been identified in mouse eggs using RT-PCR and Western analysis (Gangeswaran and Jones, 1997) . They detected PKC␦ and in germinal vesicle stage oocytes and in metaphase II eggs while other PKC isotypes (i.e., ␣, ␤, ␥, ⑀, , , and ) were absent. The presence of different isotypes of PKC in the mammalian egg supports a putative role for PKC as a direct or indirect decoder of the calcium signal. Data reported by Raz et al. (1998) suggest a direct response since PKC ␣, ␤, and ␥ are calcium-and DAG-dependent isotypes. However, the results of Gangeswaran and Jones (1997) suggest that a less direct pathway of action in decoding calcium signals since PKC␦ could respond to calcium oscillations, but PKC would not. Activation of PKC is also necessary for embryonic compaction (Winkel et al., 1990; Ohsugi et al., 1993a,b; Pauken and Capco, 1999a) , that is, the process of increased cellular adhesion, cellular reorganization, and polarization that normally occurs in the 8-to 16-cell embryo. Embryonic compaction can be induced prematurely by exposure of 2-cell or 4-cell embryos to PKC activators (Winkel et al., 1990; Ohsugi et al., 1993a,b) . Moreover, during both normal and premature compaction, PKC␣ is translocated from the cytoplasm to the plasma membrane between adjoining blastomeres, suggesting activation of this PKC isotype (Pauken and Capco, 1999a) .
The studies described above suggest that PKC isotypes have several roles during preimplantation development of mammalian embryos. The presence of more than one isotype of PKC in the egg and subsequently in blastomeres of the embryos provides the possibility of differential function of the isotypes as might be reflected by a differential localization in subcellular compartments or an embryonic stage-dependent localization, which could be identified in the highly orchestrated process of murine preimplantation development. To address these possibilities, a stagedependent analysis of the different PKC isotypes at both the mRNA and the protein levels was conducted. In addition, an immunocytochemical analysis mapped both the temporal and the spatial patterns of expression of several PKC isotypes during preimplantation development. Our data indicate which PKC isotypes are supplied maternally and which are detected after fertilization in the mouse. We show that each isotype has a specific spatial/temporal pattern of expression and that key redistributions of PKC isotypes occur around the time of embryonic compaction.
MATERIALS AND METHODS
Animals. CD-1 mice were obtained from the breeding colony at Arizona State University. Animal care and use procedures followed the U.S. Department of Health and Human Services "Guide for the Care and Use of Laboratory Animals" guidelines. Nulliparous females were injected with 5 IU of pregnant mare serum gonadotropin (Calbiochem, Inc., San Diego, CA) and 48 h later with 5 IU human chorionic gonadotropin (hCG; Sigma Chemical Co., Inc., St. Louis, MO). In order to obtain embryos the females were paired with CD-1 males overnight. The next day the females were examined for copulation plugs, the presence of which was designated gestational day (GD) 0.5. To obtain unfertilized, metaphase II eggs the females were not mated and instead the cumulus masses were removed from the oviducts 14 -16 h after hCG. Cumulus cells were removed from the eggs by treatment with hyaluronidase and the eggs washed several times before use (Pauken and Capco, 1999b) . Embryos were flushed with KSOM-H (Ho et al., 1995) from the oviducts on GD 1.5 (2-4 cells) or GD 2.5 (8 -16 cells) or from the uterine horns on GD 3.5 (blastocysts). They were cultured in KSOM (Ho et al., 1995) in a 37°C incubator with 5% CO 2 until use.
RT-PCR. Embryos were obtained at the appropriate stage and stored in the RNA lysis buffer at Ϫ80°C. Rabbit globin mRNA was added to some samples and later amplified by RT-PCR to determine if the mRNA was isolated with minimal degradation (Temeles et al., 1994) . The mRNA was extracted using the RNAeasy kit (Qiagen, Chatsworth, CA). DNA was digested using RQI RNasefree DNase (Promega, Inc., Madison, WI) following standard procedures. Adult mouse tissues were snap frozen in liquid N 2 , and the RNA was extracted with TriReagent (Sigma, Inc.) and then treated with DNase as above.
One hundred embryos were used in each reverse-transcription reaction with 500 ng oligo(dT) primer and 200 U of SuperScript II reverse transcriptase (Life Technologies, Inc., Gaithersburg, MD) in a 20-l reaction at 42°C for 60 min. Two microliters of the RT reaction mixture was then used in a 50-l PCR with 1ϫ PCR buffer II, 40 ng of each primer (see below), an optimal concentration of MgCl 2 (1.5-3.0 mM), 0.2 mM dNTPs, [
32 P]dCTP (Amersham Phar-macia Biotech, Piscataway, NJ), and 2 U of Taq (Fisher Scientific, Pittsburgh, PA). The DNA was denatured by heating the oilcovered samples for 4 min at 94°C and then amplified using the following parameters: 94°C for 20 s, 60°C for 1 min, 72°C for 3 min for 45 cycles. Control reactions run concurrently included a positive control using actin primers for each RT reaction, a negative control with no DNA added and actin primers, and a reaction using actin primers with the products from an RT reaction to which no reverse transcriptase was added to verify that all contaminating DNA had been removed. Table 1 shows the primers and amplicon size for each PCR. The primers were designed using the Williamstone software (http:// www.williamstone.com/primers/index.html) except for the PKC␤ primers, which are subsets of the primers used by Ponzoni et al. (1993) . Each primer set can amplify the proper size band from a 1:1000 dilution of the cDNA products from a RT reaction primed with 1 g ovary total RNA. The high number of PCR cycles with these primers aids in maximizing sensitivity of the detection of PKC mRNAs. The PCR products were sequenced on an ABI Prism 377 DNA sequencer system and the sequence was analyzed with BLAST software (Altschul et al., 1997) to verify the identity of the amplified sequence.
Ten-microliter aliquots of each PCR were electrophoresed on a 6% acrylamide 0.5ϫ TBE gel. After the gel was dried it was exposed to a PhosphorImager screen and analyzed on a PhosphorImager System. Each PCR was done a minimum of three times with each set of primers at each stage of development.
Antibodies. The antibodies directed against PKC␣, ␥, ␦, , and were obtained from Transduction Laboratories (Lexington, KY) while the PKC␤I and II were from Calbiochem and used at dilutions from 1/50 to 1/100 for immunocytochemistry. In addition, anti-PKC isotype antibodies for PKC␣, ␦, and to epitopes different from those supplied by Transduction Laboratories were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Another antibody directed against a different epitope on PKC was obtained from Oxford Biomedical Research, Inc. (Oxford, MI) and used at a dilution of 1:100 for immunocytochemistry.
Western blots.
Embryos were collected at the designated stage in sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 0.1 M DTT, 10% v/v glycerol). The samples were boiled for 5 min before being loaded on a precast 10% Tris-glycine gel (Bio-Rad, Hercules, CA) with molecular weight markers. After being blotted to nylon membrane using a semidry apparatus (Bio-Rad) according to the manufacturer's directions, the blots were blocked in Blotto (5% dry milk in PBS, pH 7.35, with 0.1% Tween 20) at room temperature. The blots were challenged with the primary antibody at a dilution of 1/250 -1/5000, as specified in the company's data sheet, in Blotto overnight at 4°C, washed five times with PBT (PBS, pH 7.35, with 0.1% Tween-20) at room temperature, challenged with the appropriate second antibody conjugated with horseradish peroxidase (1.6 ϫ 10 Ϫ6 g/ml; Pierce, Rockford, IL) for 1 h at room temperature, and again washed with PBT. Localization of antibodies was detected by chemiluminescence using the ECL kit (Amersham, Arlington Heights, IL) following the manufacturer's instructions. Each developmental stage was examined in a minimum of three independent experiments and provided comparable results.
Immunocytochemistry. Embryos at the appropriate stage were fixed (Pauken and Capco, 1999a) for 5 min in 0.05% glutaraldehyde, 2.0% paraformaldehyde in PBS, transferred to 2.0% paraformaldehyde in PBS for 25 min, and then permeabilized in 1% Tween 20, 2.0% paraformaldehyde in PBS for 30 min. They were washed through three changes of 5 mM glycine in PBS for a total of 1 h, then equilibrated in intracellular buffer (ICB; 100 mM KCl, 5 mM MgCl 2 , 3 mM EGTA, 20 mM Hepes, pH 6.8) containing 1% BSA for 5 min and challenged with the antibodies diluted in ICB containing 1% BSA overnight at 4°C. The embryos were then washed, and the antibodies were detected with Alexa 536-conjugated anti-mouse or -rabbit secondary antibodies (4 g/ml; Molecular Probes) and analyzed on a Leica TCS NT laser scanning confocal microscope using a 63ϫ water immersion objective and appropriate filter sets. Digitized optical images were analyzed using Molecular Dynamics Image Space software. Each antibody was used in a minimum of three separate experiments for embryos at each developmental stage. 5Ј-GTC-ATG-GAA-TAC-GTC-AAC-GGC-3Ј  1408-1428  690  5Ј-AAT-CAC-CAG-CTG-ATC-TGG-TGG-3Ј  2077-2097  PKC␤, X53532 5Ј-GGA-AGC-GAG-GGC-AAT-GAA-3Ј 928-945  218  5Ј-TCA-TCT-GTA-CCC-TTC-CGC-3Ј 1128-1145
Detergent extraction. Embryos were detergent extracted by incubating them in ICB containing 1% Tween 20 and protease inhibitors as described by Pauken and Capco (1999b) . After detergent extraction, the specimens where fixed and processed as described under Immunocytochemistry.
RESULTS

Expression at the mRNA Level
In order to determine which mRNAs coding for specific isotypes of the PKCs were expressed during different stages of preimplantation development, RT-PCR analysis was conducted using primer sequences specific for unique regions of the different isotypes of PKC (Table 1 ). The RT-PCRs were optimized for maximal sensitivity of detection of the PKC isotypes (see Materials and Methods) . RT-PCR analysis shows that in the meiotic metaphase II unfertilized eggs, mRNAs coding for PKC and are present, while mRNAs coding for PKC␣, ␤, ␥, ␦, and are not detected (Fig. 1A) . After fertilization at the two-cell stage, mRNAs coding for PKC␥ and are first detected as well as continuing expression of mRNAs for PKC and . The mRNAs coding for PKC␣, ␤, and ␦ are not detected (Fig.  1B) . At the four-cell stage mRNAs coding for PKC␥, , , and continue to be detected (Fig. 1C) . In compacting eight-cell embryos, PKC␥ and continue to be detected while detection of PKC and is variable in replicate experiments (Fig. 1D) . At the blastocyst stage, mRNAs coding for PKC␥, , and are detected (Fig. 1E) .
Using total RNA from adult mouse ovary or brain tissue the RT-PCR amplification product for each of these PKC isotypes can be detected on ethidium bromide-stained gels (Figs. 1F and 1G ). In addition, the identity of RT-PCR products from different stage embryos was confirmed by sequencing the PCR product to ensure that the amplicon was the appropriate product (data not shown). Additional controls included a positive control reaction using actin primers (i.e., lanes labeled "A") and a negative control reaction containing actin primers in which reverse transcriptase was omitted to demonstrate the removal of genomic DNA (i.e., lanes labeled "ϪRT") from the sample.
Expression at the Protein Level
PKC␣ is one of the conventional isotypes of PKC and is probably the best characterized of the PKC isotypes because it is widely expressed in both adult tissues and a number of cell lines. The PKC␣ protein is detected in the metaphase II egg (UFE) through to the eight-cell stage in decreasing amounts as determined by Western blot ( Fig. 2A) and is of the same MW (82 kDa) as detected in the brain ( Fig. 2A , "Br" lane). Only slight amounts of the protein are detected in blastocysts after long film exposures. Immunocytochemical localization of PKC␣ protein demonstrates that it is present throughout the cytoplasm of two-cell (Fig. 2B) 
FIG. 1.
RT-PCR analysis of isoform-specific expression of PKC mRNAs. RT-PCR analysis in the presence of [ 32 P]dCTP detects the expression of PKC mRNAs in (A) meiotic metaphase II unfertilized eggs (UFE), (B) 2-cell embryos, (C) 4-cell embryos, (D) 8-cell embryos, and (E) blastocysts. Ethidium bromide-stained gels show isotype-specific PKC mRNA expression in the (F) mouse ovary and (G) mouse brain. The A lanes are the actin positive control and the ϪRT lanes are the negative controls to show that no genomic DNA is present during amplification. Molecular weights are shown at the right. and four-cell embryos (Fig. 2C ) in single optical sections from a laser scanning confocal microscope. PKC␣ also can be detected in the nuclei, albeit at a lower level than the cytoplasm. Though present in the nuclei, PKC␣ is excluded from the nucleolar area in these embryos. In the eight-cell embryo, as embryonic compaction initiates, PKC␣ is enriched at the plasma membrane of blastomeres with greatest intensity at the adjoining membranes of the blastomeres (arrows) and is no longer detected in the nuclei (Fig. 2D) . As embryonic compaction continues the localization of PKC␣ becomes restricted to the region of adjoining blastomeres and continues to be excluded from nuclei (Fig. 2E) . Since RT-PCR analysis did not reveal any mRNA for PKC␣ in the fertilized egg, or at subsequent developmental stages, we employed two different antibodies that bound to different epitopes on PKC␣ for both the Western and the immunocytochemical analyses to confirm that we were detecting PKC␣ (see Materials and Methods). Both antibodies were able to detect a comparable pattern in the immunocytochemistry of the preimplantation mouse embryos.
The other conventional isotypes are PKC␤ and ␥. PKC␤ was not detected on Western blots or by immunocytochemical analysis of preimplantation embryos (data not shown). However, PKC␥ is detected on Western blots (Fig.  3A) of mouse embryos from the meiotic UFE stage with increasing amounts to the four-cell embryo stage. A de-
FIG. 2.
PKC␣ protein in the embryo. Western blots (A) detect the 82-kDa PKC␣ protein during embryogenesis in equal numbers (i.e., 75 per lane) of meiotic metaphase II eggs (UFE), 2-cell (2-C), 4-cell (4-C), compacted 8-cell (8-C), and blastocyst (Bl) stage embryos and in the adult brain (Br). Immunocytochemistry analyzed by laser scanning confocal microscopy detects the PKC␣ uniformly distributed in the cytoplasm of the 2-cell embryo and at slightly lower levels in the nucleus but not the nucleoli (B). The uniform distribution continues in the 4-cell embryo (C) but at the early 8-cell stage PKC␣ is enriched at the plasma membrane of adjoining blastomeres (arrows), but is no longer detected in the nucleus (D). As compaction proceeds, protein expression is enhanced at the apposed membranes (E). A control embryo exposed only to the second antibody is shown in inset (B). The scale bar is shown in (E).
FIG. 3.
PKC␥ protein in the embryo. Western blots (A) detect the 80-kDa PKC␥ protein during embryogenesis in equal numbers (i.e., 150 per lane) of meiotic metaphase II eggs (UFE), 2-cell (2-C), 4-cell (4-C), compacted 8-cell (8-C), and blastocyst (Bl) stage embryos and in the adult brain (Br). Immunocytochemistry analyzed by laser scanning confocal microscopy detects the PKC␥ uniformly distributed in the cytoplasm of the 2-cell embryo and at slightly lower levels in the nucleus but not the nucleoli (B). At the 4-cell stage (C), the PKC␥ protein continues to be distributed uniformly in the cytoplasm but it is no longer detected in the nuclei. As compaction proceeds during the 8-cell stage, protein expression is slightly enhanced at the plasma membranes (arrow in D) and continues to be expressed in the cytoplasm (D). At the morula stage, the protein is slightly enhanced at the apposed membranes (E). A control embryo exposed only to the second antibody is shown in inset (C). The scale bar is shown in (E). creased amount of PKC␥ is then detected at the eight-cell and blastocyst stages. Immunocytochemistry shows a uniform level of PKC␥ in the cytoplasm and nucleus, but not in the nucleoli, of two-cell embryos (Fig. 3B) . At the four-cell stage, there is still a uniform distribution in the cytoplasm but it is no longer detected in the nuclei as determined when the optical section is selected to bisect the nucleus (Fig. 3C) . As development proceeds from the eight-cell stage (Fig. 3D) through embryonic compaction to the morula stage (Fig. 3E) , a slight enrichment of PKC␥ becomes apparent at the plasma membrane of adjoining blastomeres (arrow).
PKC is an atypical PKC isotype which does not require DAG or calcium for activation. Western analysis detects the protein for PKC as two bands of 65 and 72 kDa in the adult brain (Fig. 4A) . A single band of 72 kDa is detected in the UFE and at notably lower levels in the two-cell embryo (Fig. 4A) . Increasing levels of the 72-kDa band are seen in the four-and the eight-cell stage. However, the PKC detected at the blastocyst stage is only of 65 kDa and no 72-kDa PKC is detected (Fig. 4A ). Immunocytochemistry shows that PKC is uniformly distributed throughout the cytoplasm in the two-cell embryo, is present in nuclei, but appears to be excluded from nucleoli ( Fig. 4B) . At the four-cell stage, the PKC is enriched at the plasma membrane exposed to the external milieu and at the nuclear envelope (Fig. 4C) . In the uncompacted eight-cell embryos, high levels of PKC are detected in each nucleus with notably lower levels of the protein in the cytoplasm (Fig. 4D ). This stereoscopic view results from a stack of 10 optical sections each with a thickness of 1 m. The first optical section in the stack bisects the nuclei of two blastomeres (asterisks). As compaction proceeds, the PKC protein begins to be excluded from the nuclear interior, but remains in the cytoplasm as shown when the optical section bisects the nucleus (asterisks in blastomeres from a partially compacted embryo; Fig. 4E ). At subsequent developmental stages PKC remained absent from nuclei (data not shown). Since PKC is enriched in nuclei at the early eight-cell stage, we tested whether it was floating freely within the nuclear compartment or if it was attached to the chromatin or other structural components in the nucleus and thus resistant to detergent extraction. Detergent extraction of living embryos removes membrane lipids and allows soluble components to diffuse out of the cell leaving behind the detergent-resistant cytoskeleton (Capco, 1996) . PKC remained enriched in the nuclei of Immunocytochemistry analyzed by laser scanning confocal microscopy detects PKC uniformly distributed in the cytoplasm of the 2-cell embryo and at slightly lower levels in the nucleus but not the nucleoli (B). At the 4-cell stage (C), the PKC protein is enriched at the plasma membrane exposed to the outside environment and at the periphery of the nuclei. A stereo confocal view of a stack of 10 1-m optical sections of the uncompacted 8-cell embryo (D) shows high levels of PKC in the nuclei with lower levels present in the cytoplasm of the blastomeres. The blastomeres indicated with asterisks contain nuclei that have been bisected by the optical section. As compaction proceeds, the PKC protein is absent from the nuclear interior as shown where the optical section bisects the nuclei (asterisks) (E). Detergent extraction of 8-cell embryos demonstrates that the PKC protein remains in the nuclei. (F) A control embryo exposed only to the second antibody is shown in inset (B). The scale bar is shown in (E).
early eight-cell embryos after detergent extraction (Fig.  4F) .
PKC also is an atypical PKC isotype and does not require DAG or calcium for activation. On Western blots PKC was present at all stages (data not shown). In addition, PKC exhibited a uniform distribution of protein by immunocytochemical analysis at all stages examined (data not shown).
PKC␦ is a novel isotype of PKC, requiring negatively charged phospholipids and DAG as cofactors for activation, but as with all novel isotypes, it does not have a requirement for calcium. On Western blots the 78-kDa band of PKC␦ appears at a constant level in the metaphase II egg through the four-cell stage, but then decreases at the eight-cell stage (Fig. 5A) . The PKC␦ protein is enriched in the nuclei of two-and four-cell embryos (Figs. 5B and 5C ) as can be seen in optical sections that bisect the nucleus, although some four-cell embryos do not contain PKC␦ in nuclei (Fig. 5D ). In the compacting eight-cell embryo, there is a uniform level of PKC␦ throughout the cytoplasm and it is enriched at the adjoining membrane. However, at this stage PKC␦ is excluded from the nuclei of the blastomeres (Fig. 5E ). Since PKC␦ is enriched in nuclei at the two-and four-cell stages we tested whether it was bound to components in the nuclei or floating freely within the nuclear compartment. After detergent extraction, an enrichment of PKC␦ is detected within the nucleus of two-and four-cell embryos (Figs. 5F and 5G) .
PKC is considered a distantly-related, novel isotype of PKC which is sometimes referred to as PKD (Johannes et al., 1994; Valverde et al., 1994) . Western analysis shows PKC as a 115-kDa band expressed in the UFE with a gradual decrease in level through to the eight-cell stage (Fig.  6A) . It is not detected at the blastocyst stage (Fig. 6A) . Immunocytochemistry demonstrates that it is uniformly distributed in the cytoplasm of the two-cell embryo (Fig.  6B) . At the four-cell stage there is a gradient of PKC increasing in intensity from the nucleus to the plasma membrane, with the highest level of PKC near the portion of the plasma membrane that is exposed to the outside milieu (Fig. 6C) . At the morula stage, there is an enrichment of PKC at the adjoining membranes of compacting embryos (Fig. 6D) with a speckled pattern of PKC near the outer membrane and a more uniform level throughout the FIG. 5. PKC␦ protein in the embryo. Western blots (A) detect the 78-kDa PKC␦ protein during embryogenesis in equal numbers (i.e., 150 per lane) of meiotic metaphase II eggs (UFE), 2-cell (2-C), 4-cell (4-C), compacted 8-cell (8-C), and blastocyst (Bl) stage embryos and in the adult brain (Br). Immunocytochemistry analyzed by laser scanning confocal microscopy detects a uniform distribution of PKC␦ in the cytoplasm of the 2-cell embryo with slightly higher levels in the nuclei (B). At the 4-cell stage (C), the PKC␦ protein continues to be uniformly expressed in the cytoplasm (C, D) and in the nuclei of some (C) but not all embryos (D). In the partially compacted 8-cell embryo, PKC␦ protein is present in the cytoplasm of the blastomeres and is slightly enriched at the apposing membranes as shown in this stereoscopic image composed of eight 1-m optical sections (E). When 2-C (F) or 4-C (G) embryos are detergent extracted to remove the soluble proteins before fixation, PKC␦ protein continues to be detected at high levels in the nuclei. A control embryo exposed only to the second antibody is shown in inset (D). The scale bar is shown in (G).
remainder of the cytoplasm (Fig. 6D) . PKC is excluded from nuclei of the blastomeres.
The results from the RT-PCR are summarized in Table 2 and the Western blot data are summarized in Table 3 . PKC and appear to be maternal mRNAs present until the eight-cell stage, for PKC, or the blastocyst stage, for PKC, in either the maternal or the zygotic form. PKC␣ and ␦ mRNAs are not detected at any stages although these isotypes are detected at the protein level, suggesting that they are synthesized during oogenesis for use in embryogenesis. PKC␥ and proteins are present in the unfertilized egg, but their mRNAs are not detected until the two-cell stage, suggesting that transcription of these genes is initiated during or after fertilization. PKC␤ could not be detected either at the mRNA or at the protein level during embryogenesis. Thus each PKC isotype examined has a specific temporal pattern of expression at the mRNA and protein levels.
DISCUSSION
This investigation demonstrates that the mouse egg and early embryo contain several different isotypes of PKC. The PKC isotypes PKC␥, , , and are present at the mRNA and protein levels in eggs or early embryos while PKC␣ and ␦ can be detected only at the protein level. Neither PKC␤ mRNA nor protein can be detected in eggs or preimplantation embryos. The protein levels of PKC␣ and ␦ decrease in concentration during early development and are virtually undetectable by the blastocyst stage. This decrease is not surprising since many components are synthesized by the maternal genome and stored in the egg for use in later development (Raff, 1980) . Thus the presence of PKC␣, ␥, ␦, and at the protein level in the unfertilized egg, while undetectable at the mRNA level, suggests that they were synthesized during oogenesis and stored as the maternal form of the protein. At the two-cell stage, mRNAs for PKC␥ and become detectable and the timing of their appearance suggests that they are synthesized as a result of zygotic genome activation. An alternative explanation is that the level of expression is below the sensitivity of our system; however, we tried to circumvent this possibility by optimizing the RT-PCR for sensitivity.
The results indicate that the egg and early embryonic stages contain representatives from all three categories of PKCs, the conventional (i.e., PKC␣ and ␥), the atypical (i.e., PKC and ), and the novel (i.e., PKC␦ and ) forms, at the protein level. These three categories of PKC isotypes have differing requirements for activation of the kinase and are enriched in different subcellular locations in a developmental stage-specific fashion. This presents the possibility that different isotypes of PKC are differentially activated and are involved in different events during preimplantation development.
One key developmental transition during preimplantation development is embryonic compaction, which occurs between the 8-cell and the 16-cell stage of development and is accompanied by changes in cell structure and changes in developmental fate. Changes at the cellular level include an increase in the level of cell adhesion between blastomeres of the embryo, which results in the formation of a smooth ball of blastomeres, as well as the development of cell polarity as demonstrated by the formation of an apical and basolateral surface in blastomeres of the embryo (Hyafil et al., 1980; Butz and Larue, 1995; Ohsugi et al., 1996) . At this time there also is a restriction in developmental fate in which the outer blastomeres of the embryo become destined to form the first epithelial layer, the trophectoderm, while blastomeres that reside in the center of the embryo remain pluripotent and form the inner cell mass (Tarkowski and Wroblewska, 1967; Johnson and Ziomeck, 1981) . In this investigation we show that PKC, which is an atypical PKC and does not require calcium or DAG for activation, accumulates in the nucleus of eight-cell embryos just prior to embryonic compaction. After the embryo begins to compact, PKC is excluded from the nucleus. Compaction can be induced prematurely in four-cell embryos by PKC activators (Winkel et al., 1990; Ohsugi et al., 1993a,b; Pauken and Capco, 1999) . During premature compaction PKC␣ was recruited to the plasma membrane of adjoining blastomeres, but PKC was not recruited into the nuclei of the four-cell embryos (Pauken and Capco, 1999) . This suggests that recruitment of PKC into the nuclear compartment reported here is not one of the required signals for cell adhesion, but it may function in other processes occurring in the blastomeres.
PKC␦ is also present in nuclei of the embryo, but at earlier developmental stages than PKC. PKC␦ is enriched in the nuclei of all two-cell embryos, and in some four-cell embryos, and this enrichment is retained after detergent extraction. At subsequent developmental stages, PKC␦ is excluded from the nucleus but does accumulate at the plasma membrane of adjoining blastomeres during embryonic compaction; however, its pattern of accumulation differs from that of PKC␣. The enrichment of PKC␦ in the nuclei of two-cell embryos corresponds to the time when unique transcripts are produced as part of zygotic genome activation (Davis and Schultz, 1997; Latham et al., 1995; Christians et al., 1995; Schultz et al., 1999) and these unique transcripts disappear after the two-cell stage, similar to the disappearance of PKC␦'s enrichment in nuclei of four-cell embryos. PKC␦ may have a role in regulating the expression of these unique transcripts.
PKC distribution during the four-cell stage of development resembled an inside-outside type of polarity with the highest concentration of PKC at the portions of the plasma membrane exposed to the external milieu. At the morula stage the highest concentration of PKC also is seen in the outer blastomeres again resembling an insideoutside type of polarity. PKC then decreases at the mRNA and protein level, suggesting that it may a role prior to blastocyst formation.
Recently it has been suggested that PKC␥ can serve to decode calcium signals by distinguishing between low-and high-frequency calcium oscillations and that some shortterm kinase activity can occur even in the absence of DAG (Oancea and Meyer, 1998) . Our results indicate that maternal PKC␥ is present at the protein level in unfertilized eggs, and at the two-cell stage mRNA for PKC␥ is expressed and the continued presence of PKC␥ at the protein level is seen. Thus this isotype of the kinase is present throughout fertilization and early development and may be responding to slight changes in calcium levels. PKC␥ accumulates at the plasma membrane of adjoining blastomeres during embryonic compaction in a pattern similar to that of PKC␣, but the signal intensity of PKC␥'s membrane localization is notably less. Null mutations disrupting the PKC␥ have been produced and they result in the formation of viable embryos that form adults capable of reproduction (Abeliovich et al., 1993) . Thus the function of PKC␥ during fertilization and preimplantation development either is compensated for by another PKC isotype or is not required.
The PKC isotypes we have identified at the protein and mRNA levels are similar, but not identical, to those reported in rat eggs by Raz et al. (1998) and mouse eggs by Gangeswaran and Jones (1977) . In agreement with results in rat eggs we have found PKCs ␣, ␥, ␦, , , and at the protein level, but not PKC␤ at the protein level. In the study by Gangeswaran and Jones (1997) they identified PKC␦ and at the mRNA and protein levels in both oocytes and metaphase II eggs, but did not detect any other isotypes of PKC. In the mouse metaphase II egg we detected mRNAs for PKC and , and at the protein level we could detect PKC␣, ␥, ␦, , , and . Our ability to detect additional isotypes of PKC at the mRNA level could result from our selection of primers which were designed to bind to unique regions of the PKC isotypes. We confirmed that our RT-PCR primers selected the correct products by sequencing the PCR products. Our investigation extends these earlier reports by examining the PKC isotypes at the mRNA and protein levels throughout early development and immunocytochemical analysis. There is an extensive choreography to the localization of PKC isotypes in which different isotypes exhibit different patterns at the same stage of development and throughout the process of early embryogenesis. The localization of specific PKC isotypes reported here provides clues as to possible functions of PKC isotypes that will examined in more detail in future studies.
